← Back to Patent Explorer
US5205287A Expired / Lapsed US ⏱️ 0.0 years remaining

Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents

Assignee: Hoechst AG
•
Filing: 1992-10-01
•
Granted: 1993-04-27
•
Expires: 2012-10-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to ultrasonic contrast agents composed of microparticles which contain a gas and polyamino-dicarboxylic acid-co-imide derivatives, to processes for their preparation and to their use as diagnostic and therapeutic agents.

Inventors

  • 👤 Raimund Erbel
  • 👤 Rainer Zotz
  • 👤 Volker Krone
  • 👤 Michael Magerstadt
  • 👤 Axel Walch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 08:05
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/22; A61K49/222; A61K49/223

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 239 words
A method for visualizing organs comprising using a diagnostic or therapeutic agent, wherein said diagnostic or therapeutic agent comprises one or more ultasonic contrast agent composed of microparticles which contain a gas and a polyaminodicarboxylic acid-co-imide derivative of the formula I ##STR4## in which n is 1 or 2 x is 1 to 500 y is 1 to 500, where x+y is 2 to 1000, and R is O--R 1 or NH--R 2 , in which R 2 is H, (CH 2 ) m --OR 1 , (CH 2 ) m --O--C(O)--R 1 or (CH 2 ) m --O--C(O)--OR 1 , and m is 2 to 6, and R 1 is H, aryl, aralkyl, arylalkenyl, alkyl or C 3 -C 8 -cycloalkyl or a biologically inactive steroid alcohol or an amino acid, where aryl is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 1 -C 4 -alkylcarbonyloxy, C 1 -C 4 -alkoxy or hydroxyl, where the alkyl radicals specified for R 1 have 1-22 carbon atoms and the alkenyl radicals have 2-22 carbon atoms, which are not interrupted or are interrupted by a carbonyloxy or oxycarbonyl group, where the repeating units placed in square brackets are distributed randomly and/or in blocks in the polymer, and where both the repeating units labeled with x and those labeled with y are identical or different and where the amino acids are α- and/or β-linked.
Claim 2
Independent Claim 239 words
A method for visualizing organs comprising using a diagnostic or therapeutic agent, wherein said diagnostic or therapeutic agent comprises one or more ultasonic contrast agent composed of microparticles which contain a gas and a polyaminodicarboxylic acid-co-imide derivative of the formula I ##STR4## in which n is 1 or 2 x is 1 to 500 y is 1 to 500, where x+y is 2 to 1000, and R is O--R 1 or NH--R 2 , in which R 2 is H, (CH 2 ) m --OR 1 , (CH 2 ) m --O--C(O)--R 1 or (CH 2 ) m --O--C(O)--OR 1 , and m is 2 to 6, and R 1 is H, aryl, aralkyl, arylalkenyl, alkyl or C 3 -C 8 -cycloalkyl or a biologically inactive steroid alcohol or an amino acid, where aryl is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 1 -C 4 -alkylcarbonyloxy, C 1 -C 4 -alkoxy or hydroxyl, where the alkyl radicals specified for R 1 have 1-22 carbon atoms and the alkenyl radicals have 2-22 carbon atoms, which are not interrupted or are interrupted by a carbonyloxy or oxycarbonyl group, where the repeating units placed in square brackets are distributed randomly and/or in blocks in the polymer, and where both the repeating units labeled with x and those labeled with y are identical or different and where the amino acids are α- and/or β-linked.
Claim 3
Dependent Claim 24 words
A method for investigating cavities in humans, animals or plants comprising using one or more diagnostic or therapeutic agent as defined in claim 1.
Claim 4
Dependent Claim 20 words
A method for diagnosing cardiovascular disorders comprising using one or more diagnostic or therapeutic agent as defined in claim 1.

References Cited (Backward Citations)

US4276885A Cited
EP0122624A2 Cited
EP0123235A2 Cited
EP0224934A2 Cited
EP0274127A2 Cited
US4906473A Cited
US5041291A Cited
EP0327490A1 Cited
DE4002736A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-04-26 1996-10-26 1997-04-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-04-26 2000-10-26 2001-04-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-04-26 2004-10-26 2005-04-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag